Skip to main content
. 2021 Mar 25;13(7):1508. doi: 10.3390/cancers13071508

Figure 2.

Figure 2

PSMA-PET/CT in maximum intensity projection (MIP) (A) of a 70-years old patient with prostate cancer (GS 7b/group grade 3, PSA 4.53 ng/mL) and low intraprostatic SUVmax (3.45) and no metastases (B) PSMA-PET Dx; (C) PSMA PET/CT Dx.